Jazz Pharma (JAZZ) Posts Q4 EPS of $0.17, Tops by 10c; Guides FY10 EPS Above Street
Tweet Send to a Friend
Jazz Pharma (NASDAQ: JAZZ) reports Q4 EPS of $0.17 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
